http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-970702037-A
Outgoing Links
| Predicate | Object |
|---|---|
| filingDate | 1995-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1997-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-970702037-A |
| titleOfInvention | Pharmaceutical compositions for the treatment of delayed dyskinesia and uses thereof |
| abstract | Provided is a pharmaceutical composition for treating delayed dyskinesia containing a compound having an enzyme inhibitory activity against phosphodiesterase as an active ingredient. As an active ingredient, rolipram is preferable. Administration of rolipram in the experimental model of delayed dyskinesia induced by rats by continuous administration of haloperidol provides a therapeutic effect that suppresses delayed dyskinesia symptoms in a dose-dependent manner. |
| priorityDate | 1994-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 15.